CCNB1 and cancer: These molecular alterations suggest that EVO-induced arrest results from inactivation of the cyclin B1-cdc2 complex and enhancement of p21-dependent checkpoint control—key pathways that suppress cell cycle progression in rapidly dividing cancer cells.